Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2022 Financial Results | News
MISSISSAUGA, ON, Could 26, 2022 /PRNewswire/ – Covalon Systems Ltd. (the “Organization” or “Covalon”) (TSXV: COV) (OTC: CVALF), an innovative professional medical technologies company, will launch its Q2 Fiscal 2022 financial results on Monday May well 30th, 2022, right before marketplaces open. A conference simply call and webcast to focus on the economical outcomes will be held on Monday Might 30th, 2022, at 9:00am EST.
To watch, hear to, and participate in the reside webcast, please abide by the url under:
https://produceredition.webcasts.com/starthere.jsp?ei=1551026&tp_crucial=74c818f1fa
To pay attention and take part by means of the conference connect with, be sure to dial:
North American Toll-Free of charge: 1-888-664-6392
Regional (Toronto): 416-764-8659
Affirmation Variety: 10020730
Members will be capable to question issues of Corporation administration for the duration of the Q&A part of the meeting get in touch with both by asking them on the connect with or by publishing them using the chat operate on the webcast.
A recording of the simply call will be accessible by contacting 1-888-390-0541 or 416-764-8677 and coming into the encore replay entry code 020730# right until June 13th, 2022. A recording of the phone will also be offered on www.covalon.com below News & Gatherings on the Investors tab.
Copies of Covalon’s financial statements and MD&A can be obtained on SEDAR at www.sedar.com and below Sedar Filings on the Buyers tab of Covalon’s web page.
About Covalon
Covalon Systems Ltd. is a researcher, developer, manufacturer, and marketer of patent-guarded healthcare goods that increase affected person results and save life in the spots of innovative wound care, an infection administration and surgical strategies. Covalon leverages its patented professional medical technological know-how platforms and skills in two techniques: (i) by producing items that are marketed under Covalon’s title and (ii) by establishing and commercializing professional medical products and solutions for other healthcare organizations under progress and license contracts. The Corporation is stated on the TSX Undertaking Exchange, acquiring the image COV and trades on the OTQX Sector under the symbol CVALF. To discover far more about Covalon, pay a visit to our web-site at www.covalon.com.
Neither TSX Enterprise Exchange nor its Regulation Expert services Company (as that phrase is defined in the insurance policies of the TSX Enterprise Trade) accepts obligation for the adequacy or precision of this launch.
This information launch is made up of ahead-hunting statements which reflect the Company’s recent anticipations concerning upcoming activities. The ahead-seeking statements are generally, but not constantly, identified by the use of text these types of as “look for”, “foresee”, “system, “estimate”, “anticipate”, “intend” and statements that an celebration or consequence “may perhaps”, “will”, “really should”, “could” or “could possibly” arise or be achieved and other comparable expressions. These forward-wanting statements include chance and uncertainties, like the difficulty in predicting product or service approvals, acceptance of and needs for new solutions, the effects of the products and solutions and pricing strategies of rivals, delays in creating and launching new solutions, the regulatory environment, fluctuations in running benefits, the impact and timing of COVID-19 on operating things to do and market place circumstances, and other dangers, any of which could induce success, overall performance, or achievements to differ materially from the final results mentioned or implied in the forward-on the lookout statements. Several risks are inherent in the field other folks are a lot more precise to the Corporation. Buyers really should consult with the Firm’s ongoing quarterly filings for more data on challenges and uncertainties relating to these forward-on the lookout statements. Traders ought to not spot undue reliance on any ahead-seeking statements. The Firm assumes no obligation to update or change any ahead-seeking statements no matter whether as a outcome of new details, additional functions or otherwise.
Watch primary material to down load multimedia:https://www.prnewswire.com/information-releases/covalon-announces-conference-phone-to-focus on-second-quarter-fiscal-2022-money-benefits-301555723.html
Resource Covalon Technologies Ltd.